Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels

Tait D. Shanafelt, Bijan J. Borah, Heidi D. Finnes, Kari G. Chaffee, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Sameer A. Parikh, Susan L. Slager, Neil E. Kay, Tim G. Call

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences